• Filing Date: 2018-11-14
  • Form Type: 10-Q
  • Description: Quarterly report
v3.10.0.1
KFBV Loans and Derivative Liability Disclosure (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2015
Dec. 31, 2017
Dec. 17, 2015
Sep. 08, 2014
Jul. 28, 2014
Mar. 10, 2014
Jan. 15, 2014
Accretion expense   $ 1,046,271              
Financing costs   362,720              
First KF Business Ventures Loan Agreement                  
Loan agreement                 $ 2,000,000
Common stock that may be exercised by warrants           2,350,000   6,904,546  
Exercise price per warrant share         $ 0.10 $ 0.50   $ 1.00  
Interest expense recorded $ 359,189 293,378              
Accretion expense   73,250              
Derivative liability 31,347     $ 53,439          
Second KF Business Ventures Loan Agreement                  
Loan agreement             $ 2,400,000    
Common stock that may be exercised by warrants         1,337,320   9,600,000    
Exercise price per warrant share         $ 0.10   $ 0.50    
Interest expense recorded 402,191 328,501              
Accretion expense   165,212              
Derivative liability 32,812     56,024          
Third KF Business Ventures Loan Agreement                  
Loan agreement         $ 1,500,000        
Common stock that may be exercised by warrants         8,000,000        
Exercise price per warrant share         $ 0.10        
Interest expense recorded 224,255 183,166              
Accretion expense   807,809              
Third KF Warrants                  
Derivative liability 24,000     48,000          
Third KF Loan Conversion Feature                  
Derivative liability $ 2,318,741     $ 1,968,174          
KF Business Ventures Deferred Financing Costs                  
Legal Fees     $ 50,538            
Financing costs   $ 564